School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, Zhengzhou, 450001, China.
Small. 2021 Dec;17(51):e2104722. doi: 10.1002/smll.202104722. Epub 2021 Oct 20.
Low-dose photodynamic therapy (PDT) holds great promise for reducing undesired patient photosensitivity in cancer treatment. Yet, its therapeutic effect is significantly affected by intracellular cytoprotective processes, such as autophagy. Here, an efficient autophagy suppressor is developed, which is a multifunctional DNA nanoflower (DNF) consisted of tumor-targeting aptamers and DNAzymes for silencing autophagy-related genes, with surface modification of low-dose photosensitizer (Ce6). It is found that the multifunctional DNF can specifically target tumor cells and generate reactive oxygen species (ROS) under light irradiation to trigger self-disassembly of DNF, enhancing the bioavailability of encoded DNAzymes, leading to amplified autophagy suppression. As a facile spatiotemporally programmable photogene therapy platform, the designed DNF is able to suppress tumor growth in vivo with a very low injection dose of Ce6 (18 µg kg , around 100 times lower than the generally applied dose), representing a promising strategy for cancer therapy with safely low-dose PDT.
低剂量光动力疗法(PDT)在降低癌症治疗中患者非预期的光敏性方面具有很大的应用前景。然而,其治疗效果受到细胞内细胞保护过程的显著影响,如自噬。在这里,开发了一种高效的自噬抑制剂,它是一种由肿瘤靶向适体和 DNA 酶组成的多功能 DNA 纳米花(DNF),用于沉默自噬相关基因,并对低剂量光敏剂(Ce6)进行表面修饰。研究发现,多功能 DNF 可以特异性地靶向肿瘤细胞,并在光照下产生活性氧(ROS),从而触发 DNF 的自组装,提高编码 DNA 酶的生物利用度,从而增强自噬抑制作用。作为一种简便的时空可编程的光基因治疗平台,设计的 DNF 能够以非常低的 Ce6 注射剂量(18μgkg,约为通常应用剂量的 100 倍)在体内抑制肿瘤生长,为低剂量 PDT 治疗癌症提供了一种很有前途的策略。